aDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Rockville, Maryland
bKarmanos Cancer Institute and Department of Family Medicine, Wayne State University, Detroit, Michigan
cDepartment of Pharmacology and Toxicology and James Graham Brown Cancer Center, University of Louisville School of Medicine, Louisville, Kentucky
dFred Hutchinson Cancer Research Center and the University of Washington, Seattle, Washington
eUniversity of Southern California, Los Angeles, California
fDepartment of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota and University of Iowa, Iowa City, Iowa
gCore Genotyping Facility, Advanced Technology Center, National Cancer Institute, Gaithersburg, Maryland, USA
Correspondence and requests for reprints to Lindsay M. Morton, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, 6120 Executive Boulevard, EPS/7073, MSC#7234, Rockville, MD 20852, USA
Tel: +1 301 435 3972; fax: +1 301 402 0916;
e-mail: [email protected]
Sponsorship: This research was supported by the Intramural Research Program of the NIH, National Cancer Institute, with Public Health Service (PHS) contracts N01-PC-65064, N01-PC-67008, N01-PC-67009, N01-PC-67010 and N02-PC-71105.
Received 16 December 2005 Accepted 24 February 2006
